Articles
Page 5 of 19
-
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P230
-
Leukocyte extract reduces HIV replication and modulates cellular factors involved in HIV infection: therapeutic meant
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P226 -
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P224 -
Causes of death in patients infected with HIV from 1985 to 2008
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P222 -
Clinical profile of HIV/AIDS patients admitted to a tertiary outpatient clinic in Istanbul, Turkey
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P220 -
Review of HIV testing at a district general hospital in an area of high HIV prevalence following the introduction of new national guidelines
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P218 -
Cancer chemotherapy: early experience with combined chemotherapy for HIV-infected Kaposi's sarcoma patients at Lighthouse clinic, Lilongwe, Malawi
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P216 -
A minority of tuberculosis cases occurring during HIV care is possibly preventable
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P194 -
Immunological diagnosis of CMV infection in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P192 -
Treatment of chronic invasive fungal sinusitis with voriconazole in an HIV patient
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P190 -
Moringa oleifera supplementation by patients on antiretroviral therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P188 -
Effect of intrinsic and extrinsic factors on the pharmacokinetics of TMC278 in antiretroviral-naïve, HIV-1-infected patients in ECHO and THRIVE
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P186 -
Population pharmacokinetic modelling of once-daily ritonavir-boosted darunavir in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P184 -
Salvage therapy with raltegravir in a 3-month-old infant
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P157 -
Promoting presumptive diagnosis of severe HIV disease to increase uptake of antiretroviral therapy in HIV-infected infants
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P155 -
Comparative evaluation of ARV therapy efficiency among patients at the Kiev regional AIDS center
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P153 -
CCR5 D32 modifies 15-year mortality risk associated with well-established clinical and immunological factors among HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P151 -
Development of a single-tube, low-cost, analytical process to extract, separate and determine efavirenz and rifampicin plasma concentrations in HIV/TB co-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P149 -
Feasibility of testing antibodies to HIV from filter paper using HIV rapid test kits
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P147 -
Naïve patients receiving TDF/FTC-EFV as 2 pills are more likely to modify regimen components than patients receiving a TDF/FTC/EFV single pill
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P122 -
Does feedback of medication execution using MEMS caps aid adherence to HAART?: the MEMRI study (MEMS as Realistic Intervention)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P120 -
Relating protease inhibitor resistance at time of virological failure with drug exposure
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P118 -
Adherence, quality of life and number of daily pills in a large cross-sectional study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P116 -
Administration of darunavir tablets in patients with difficulties in swallowing – two case reports
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P114 -
Efavirenz use and contraceptive methods in HIV-positive women in a large urban cohort
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P112 -
Drug interactions in the elderly HIV-infected patient
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P108 -
Quantitative ultrasound (QUS) in HIV-infected patients: a reliable and low-cost technique for bone health assessment
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P98 -
Lack of association between mitochondrial DNA polymorphisms and didexoxynucleoside-induced hyperlactataemia in black-African, HIV-1-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P96 -
A case of nodular regenerative hyperplasia in a patient who had been taking didanosine
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P94 -
Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P92 -
The association between metabolic syndrome and the occurrence of nephrolithiasis in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P88 -
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P63 -
Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P61 -
Abstract withdrawn
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P59 -
British HIV and ageing study. HIV and ageing: older people with HIV, who are they?
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P57 -
The prognosis of patients with dissociated virological and immunological responses to HAART
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P55 -
Epidemiological description of the demographic and HIV disease characteristics of HIV patients who are in care but not on treatment in Spain
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P53 -
Lersivirine: a new NNRTI active across HIV-1 subtypes with a unique resistance profile
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O49 -
The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O47 -
Eligibility for the initiation of HIV treatment in the context of the updated EACS guidelines: results of a clinical audit
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P22 -
O214. Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O20 -
Sex matters: retrospective data collection on the date of commencement of ART for HIV-positive women and men in the German KompNet cohort (1991-2009)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P20 -
Immunological response among patients with undetectable viral load followed for 5 years
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P18 -
Impact of timing HAART initiation on immune status and clinical course in the cohort of the German competence network for HIV/AIDS
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P16 -
O133. Test and treat — community perspectives
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O14 -
O131. Treatment as prevention within the framework of current guidelines
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O12 -
O115. Low-level residual viremia and risk of virological failure
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O5 -
O113. Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O3 -
The public health implications of antiretroviral therapy – 2011 and beyond
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):K2 -
O111. The changing face of HIV resistance; HIV drug resistance north and south — what's next?
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O1